NR4A1 and cancer: In these patients, hormone stimulation to regulate ovulatory cycles and prepare for oocyte recruitment is potentially dangerous since specific molecular pathways of hormonal receptors are highly sensitive to the excess of estrogen bioavailability both in cancer cells and in other tissues expressing those receptors.